Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biomerica, Inc. (BMRA)

3.8043   -0.006 (-0.15%) 12-06 10:03
Open: 3.82 Pre. Close: 3.81
High: 3.82 Low: 3.8043
Volume: 5,004 Market Cap: 51(M)

Technical analysis

as of: 2022-12-06 9:46:21 AM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.87     One year: 5.68
Support: Support1: 3.46    Support2: 3.02
Resistance: Resistance1: 4.17    Resistance2: 4.87
Pivot: 3.74
Moving Average: MA(5): 3.67     MA(20): 3.59
MA(100): 3.41     MA(250): 3.65
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 61     %D(3): 54.3
RSI: RSI(14): 55.4
52-week: High: 5.25  Low: 2.55
Average Vol(K): 3-Month: 93 (K)  10-Days: 29 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BMRA ] has closed below upper band by 43.7%. Bollinger Bands are 45.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.05 - 4.07 4.07 - 4.08
Low: 3.54 - 3.56 3.56 - 3.58
Close: 3.73 - 3.77 3.77 - 3.8

Company Description

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Headline News

Fri, 02 Dec 2022
What is the Market's View on Biomerica Inc (BMRA) Stock's Price and Volume Trends Friday? - InvestorsObserver

Thu, 01 Dec 2022
We Think Shareholders May Consider Being More Generous With Biomerica, Inc.'s (NASDAQ:BMRA) CEO Compensation Package - Yahoo Finance

Tue, 29 Nov 2022
New AI sorting technology to reduce battery fires in WEEE wins pilot funding -

Tue, 22 Nov 2022
Lack of enforcement ‘biggest facilitator’ of scrap thefts, BMRA says -

Tue, 15 Nov 2022
BMRA calls for ban on households placing e-waste in roadside collection bins -

Sat, 15 Oct 2022
Biomerica First Quarter 2023 Earnings: US$0.16 loss per share (vs US$0.12 loss in 1Q 2022) - Simply Wall St

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 13 (M)
Shares Float 12 (M)
% Held by Insiders 8.9 (%)
% Held by Institutions 21.9 (%)
Shares Short 510 (K)
Shares Short P.Month 351 (K)

Stock Financials

EPS -0.29
EPS Est Next Qtl 0
EPS Est This Year -0.1
EPS Est Next Year -0.18
Book Value (p.s.) 0.62
Profit Margin (%) -26.3
Operating Margin (%) -26.4
Return on Assets (ttm) -28.1
Return on Equity (ttm) -59.1
Qtrly Rev. Growth 29.7
Gross Profit (p.s.) 0.22
Sales Per Share 1.43
EBITDA (p.s.) -0.36
Qtrly Earnings Growth 0
Operating Cash Flow -2 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -13.61
PEG Ratio 0
Price to Book value 6.14
Price to Sales 2.65
Price to Cash Flow -24.03

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.